Notably, of the overall cohort of EGFR T790M-positive lung cancer patients, 151 (8.2%) had EGFR C797S identified in their clinical cfDNA testing, considerably more frequent versus the 1.2% prevalence of L792 variants. This evidence concerns the gene EGFR and lung carcinoma.